Effect of Regular Khat Chewing on Serum Fasting Sugar Level in Diabetic patients versus Healthy Individuals; A comparative study.

Diabetes mellitus Fasting blood sugar Khat Risk factors

Journal

Nutrition and metabolic insights
ISSN: 1178-6388
Titre abrégé: Nutr Metab Insights
Pays: United States
ID NLM: 101550186

Informations de publication

Date de publication:
2021
Historique:
received: 23 04 2021
accepted: 08 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 12 8 2021
Statut: epublish

Résumé

Khat chewing is a long standing social-cultural habit in several countries. Even though many people chew khat simply for its pleasurable and stimulatory effect, evidence showed widely-held belief among khat chewers in Ethiopia and other part of the world that khat helps to lower blood glucose while some studies are contradicted on the effect of khat. There is limited data about khat's effect on blood glucose especially in our setting, Harar estern Ethiopia. Primarily the present study aims to compare fasting blood sugar level among khat chewer diabetic and healthy individuals, and to asses risk factors associated with poor glycemic control in diabetic subjects. A cross-sectional study included 200 confirmed diabetic and healthy subjects. Fasting blood sugar was determined by enzymatic method glucose oxidase and glucose hexokinase. Glycemic control was also determined for diabetic subjects based on the last 2-month diabetic clinic visits and current measurement. (Median ± IQR [interquartile range]) fasting blood sugar difference among Khat chewer and non khat chewer were 159 ± 83 mg/dl and 202 ± 79 mg/dl respectively in diabetic subjects when tested by glucose oxidase. Similarly, in healthy non khat chewer and khat chewer, khat chewers has lower (Median ± IQR) fasting blood glucose level 82 ± 18 mg/dl than non khat chewers 94 ± 13 mg/dl when tested by glucose oxidase. Regarding risk factors associated with poor glycemic control in diabetic subjects, positive parental diabetes history, insulin medication, being overweight, obese were significantly associated with poor glycemic control. There was significant effect of khat on median FBS among khat chewers in diabetic and healthy individuals. And the proportion of glycemic control was high among diabetic subjects. Health care professional and patients should manage the risk factors to delay disease progression and restrain the damage. More studies should be conducted in randomized control trial manner to further elucidate khat effect on blood sugar level so that the actual effect of khat can be identified unlike in cross sectional where there may not be strong causal relationship.

Sections du résumé

BACKGROUND BACKGROUND
Khat chewing is a long standing social-cultural habit in several countries. Even though many people chew khat simply for its pleasurable and stimulatory effect, evidence showed widely-held belief among khat chewers in Ethiopia and other part of the world that khat helps to lower blood glucose while some studies are contradicted on the effect of khat. There is limited data about khat's effect on blood glucose especially in our setting, Harar estern Ethiopia.
OBJECTIVE OBJECTIVE
Primarily the present study aims to compare fasting blood sugar level among khat chewer diabetic and healthy individuals, and to asses risk factors associated with poor glycemic control in diabetic subjects.
METHOD METHODS
A cross-sectional study included 200 confirmed diabetic and healthy subjects. Fasting blood sugar was determined by enzymatic method glucose oxidase and glucose hexokinase. Glycemic control was also determined for diabetic subjects based on the last 2-month diabetic clinic visits and current measurement.
RESULT RESULTS
(Median ± IQR [interquartile range]) fasting blood sugar difference among Khat chewer and non khat chewer were 159 ± 83 mg/dl and 202 ± 79 mg/dl respectively in diabetic subjects when tested by glucose oxidase. Similarly, in healthy non khat chewer and khat chewer, khat chewers has lower (Median ± IQR) fasting blood glucose level 82 ± 18 mg/dl than non khat chewers 94 ± 13 mg/dl when tested by glucose oxidase. Regarding risk factors associated with poor glycemic control in diabetic subjects, positive parental diabetes history, insulin medication, being overweight, obese were significantly associated with poor glycemic control.
CONCLUSION CONCLUSIONS
There was significant effect of khat on median FBS among khat chewers in diabetic and healthy individuals. And the proportion of glycemic control was high among diabetic subjects.
RECOMMENDATION CONCLUSIONS
Health care professional and patients should manage the risk factors to delay disease progression and restrain the damage. More studies should be conducted in randomized control trial manner to further elucidate khat effect on blood sugar level so that the actual effect of khat can be identified unlike in cross sectional where there may not be strong causal relationship.

Identifiants

pubmed: 34376995
doi: 10.1177/11786388211035220
pii: 10.1177_11786388211035220
pmc: PMC8320567
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11786388211035220

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Diabetes Metab Syndr Obes. 2018 Jan 31;11:15-21
pubmed: 29430192
Malays J Med Sci. 2003 Jul;10(2):40-9
pubmed: 23386796
BMC Endocr Disord. 2019 Aug 29;19(1):91
pubmed: 31464602
J Clin Invest. 1996 Jan 1;97(1):22-8
pubmed: 8550838
PLoS One. 2018 Mar 5;13(3):e0193442
pubmed: 29505602
Crit Care Med. 2007 Sep;35(9 Suppl):S508-18
pubmed: 17713401
J Ethnopharmacol. 2016 Jun 20;186:30-43
pubmed: 27025406
East Mediterr Health J. 2007 May-Jun;13(3):706-18
pubmed: 17687845
Diabetes Metab Syndr Obes. 2020 Feb 10;13:307-312
pubmed: 32104027
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1147-66
pubmed: 18561890
Addict Health. 2011 Summer-Autumn;3(3-4):137-49
pubmed: 24494129
Phytother Res. 2002 Aug;16(5):403-13
pubmed: 12203257
J Diabetes Res. 2020 Jan 28;2020:5901569
pubmed: 32090121
Diabetes Metab Syndr. 2021 Mar-Apr;15(2):565-568
pubmed: 33689938
Afr J Tradit Complement Altern Med. 2008 Apr 10;5(3):271-7
pubmed: 20161948
J Ethnopharmacol. 2010 Dec 1;132(3):540-8
pubmed: 20621179
J Ethnopharmacol. 2003 May;86(1):45-9
pubmed: 12686440
BMC Res Notes. 2017 Nov 15;10(1):597
pubmed: 29141693
Br J Clin Pharmacol. 2003 Jul;56(1):125-30
pubmed: 12848785
World Health Organ Tech Rep Ser. 2006;(942):i, 1-21, 23-4 passim
pubmed: 17373571
BMC Res Notes. 2016 Feb 09;9:78
pubmed: 26861243
Postgrad Med. 2020 Nov;132(8):676-686
pubmed: 32543261
Diabetes. 2002 Feb;51 Suppl 1:S130-3
pubmed: 11815471
Home Healthc Now. 2017 Jun;35(6):339-340
pubmed: 28562405
Indian J Med Res. 2007 Nov;126(5):471-4
pubmed: 18160753
J Ethnopharmacol. 1995 Dec 1;49(2):111-3
pubmed: 8847883
J Diabetes Res. 2014;2014:137919
pubmed: 25019091
Diabetes. 2002 Jun;51(6):1737-44
pubmed: 12031960

Auteurs

Yordanos Mengistu (Y)

Department of Medical Laboratory, School of Allied Health Sciences, Health Science College, Addis Ababa University, Ethiopia.

Gobena Dedefo (G)

Department of Medical Laboratory, School of Allied Health Sciences, Health Science College, Addis Ababa University, Ethiopia.

Mesay Arkew (M)

Department of Medical Laboratory, College of Health and Medical Science, Haramaya University, Ethiopia.

Gebeyehu Asefa (G)

Armauer Hanson Research institute, Addis Ababa, Ethiopia.

Gutema Jebessa (G)

Armauer Hanson Research institute, Addis Ababa, Ethiopia.

Abay Atnafu (A)

Armauer Hanson Research institute, Addis Ababa, Ethiopia.

Zerihun Ataro (Z)

Department of Medical Laboratory, College of Health and Medical Science, Haramaya University, Ethiopia.

Samuel Kinde (S)

Department of Medical Laboratory, School of Allied Health Sciences, Health Science College, Addis Ababa University, Ethiopia.

Classifications MeSH